About Werewolf Therapeutics, Inc. 
Werewolf Therapeutics, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 12 Schemes (8.75%)
Foreign Institutions
Held by 27 Foreign Institutions (3.31%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
-18 Million
Pharmaceuticals & Biotechnology
USD 61 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-1.18
-183.75%
1.47






